Division of Endocrinology, Diabetes & Metabolic Diseases
Leadership
Position:
- Director, Division of Endocrinology, Diabetes, & Metabolic Diseases
- Professor of Medicine
Organization:
Department of Medicine
Email:
[email protected]
Contact
Name:
Division of Endocrinology, Diabetes & Metabolic Diseases
Walnut Towers
211 South Ninth Street, Suite 600
Philadelphia, PA
Contact Number(s):
- 215-955-1925
- 215-928-3160 (fax)
Research Activities
Publications
- Promotion of Cardiovascular Health in Africa: The Alliance for Medical Research in Africa (AMedRA) Expert Panel
- Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
- Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists
- Nutrition: Chronic Disease Management
- Nutrition: Malnutrition and Dietary Intake Modification
- Nutrition: Micronutrients
- Nutrition: Macronutrients
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
- Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery
- Liver Transplantation in a Woman with Mahvash Disease
- Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial
- Comorbidity clusters and in-hospital outcomes in patients admitted with acute myocardial infarction in the USA: A national population-based study
- Alternative Genetic Diagnoses in Axenfeld–Rieger Syndrome Spectrum
- Primary adrenal angiosarcoma: A case report and review of the literature
- Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions
- Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks
- Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry